In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services project, we describe the development of a dimensional rating system for Axis I disorders.
Methods
We evaluated 1,600 psychiatric outpatients with a semi-structured diagnostic interview for Axis I disorders and completed a self-report measure of psychosocial morbidity. A Standardized Clinical Outcome Rating (SCOR), a 7-point dimensional rating, was made for 17 Axis I disorders and 1 symptom construct.
Results
The dimensional ratings were highly reliable. After controlling for the number of Axis I disorders, each of the partial correlations between the dimensional rating and the measures of psychosocial morbidity was significant (mean partial r = 0.21). However, when the dimensional score was controlled, none of the partial correlations between the sum of the number of Axis I disorders and measures of psychosocial morbidity were significant (mean partial r = 0.03).
Conclusions
The SCORs are brief standardized outcome ratings that clinicians can incorporate into routine clinical practice without incurring undue burden. These ratings could make it more feasible to conduct effectiveness studies in clinical practice and to extend measurement-based care recommendations to include clinical ratings as well as self-report assessments.
Get full access to this article
View all access options for this article.
References
1.
FrancesA.Categorical and dimensional systems of personality diagnosis: a comparison. Compr Psychiatry. 1982;23:516–527.
2.
WidigerTA, SamuelDB.Diagnostic categories or dimensions? A question for the Diagnostic And Statistical Manual of Mental Disorders–fifth edition. J Abnorm Psychol. 2005;114:494–504.
3.
WidigerTA.The DSM-III-R categorical personality disorder diagnoses: a critique and an alternative. Psychological Inquiry. 1993;4:75–90.
4.
SkodolAE, OldhamJM, BenderDS, . Dimensional representations of DSM-IV personality disorders: relationships to functional impairment. Am J Psychiatry. 2005;162:1919–1925.
5.
LorangerAW, SusmanVL, OldhamJM, . The Personality Disorder Examination (PDE): a preliminary report. J Pers Disord. 1987;1:1–13.
6.
WidigerTA, TrullTJ, HurtSW, . A multidimensional scaling of the DSM-III personality disorders. Arch Gen Psychiatry. 1987;44:557–563.
7.
HeumannKA, MoreyLC.Reliability of categorical and dimensional judgments of personality disorder. Am J Psychiatry. 1990;147:498–500.
8.
ZanariniMC, SkodolAE, BenderD, . The Collaborative Longitudinal Personality Disorders Study: reliability of axis I and II diagnoses. J Pers Disord. 2000;14:291–299.
9.
DurbinCE, KleinDN.Ten-year stability of personality disorders among outpatients with mood disorders. J Abnorm Psychol. 2006;115:75–84.
10.
GriloCM, SanislowCA, GundersonJG, . Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. J Consult Clin Psychol. 2004;72:767–775.
11.
MoreyLC, HopwoodCJ, GundersonJG, . Comparison of alternative models for personality disorders. Psychol Med. 2007;37:983–994.
12.
WidigerTA, LoweJR.A dimensional model of personality disorder: proposal for DSM-V. Psychiatr Clin North Am. 2008;31:363–378., v.
13.
ClarkLA.Assessment and diagnosis of personality disorder: perennial issues and an emerging reconceptualization. Annu Rev Psychol. 2007;58: 227–257.
14.
TrullTJ, DurrettCA.Categorical and dimensional models of personality disorder. Annu Rev Clin Psychol. 2005;1:355–380.
15.
GroveWM, TellegenA.Problems in the classification of personality disorders. J Pers Disord. 1991;5:31–41.
16.
VerheulR.Clinical utility of dimensional models for personality pathology. J Pers Disord. 2005;19:283–302.
17.
HaslamN.Categorical versus dimensional models of mental disorder: the taxometric evidence. Aust N Z J Psychiatry. 2003;37:696–704.
18.
HaslamN, KimHC.Categories and continua: a review of taxometric research. Genet Soc Gen Psychol Monogr. 2002;128:271–320.
19.
ZimmermanM, PosternakMA, ChelminskiI, . Standardized clinical outcome rating scale for depression for use in clinical practice. Depress Anxiety. 2005;22:36–40.
20.
FirstMB, SpitzerRL, GibbonM, . Structured clinical interview for DSM-IV axis I disorders, patient edition (SCID-I/P, version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995.
21.
ZimmermanM, MattiaJI.Psychiatric diagnosis in clinical practice: is comorbidity being missed? Compr Psychiatry. 1999;40:182–191.
22.
ZimmermanM, McGlincheyJB, ChelminskiI, . Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a semi-structured diagnostic interview. Psychol Med. 2008;38:199–210.
23.
KesslerR, ChiuW T, DemlerO, . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–627.
24.
ZimmermanM, SheeranT, YoungD.The Diagnostic Inventory for Depression: a self-report scale to diagnose DSM-IV for major depressive disorder. J Clin Psychol. 2004;60:87–110.
25.
ZimmermanM, RuggeroCJ, ChelminskiI, . Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life. J Clin Psychiatry. 2006;67:1536–1541.
26.
ZimmermanM, ChelminskiI, YoungD, . Does DSM-IV already capture the dimensional nature of personality disorders?J Clin Psychiatry.2011;72:1333–1339.
27.
RegierDA, NarrowWE, KuhlEA, . The conceptual development of DSM-V. Am J Psychiatry. 2009;166:645–650.
28.
RounsavilleB, AlarconR, AndrewsG, . Basic nomenclature issues for DSM-V. In: A research agenda for DSM-V. KupferD, FirstM, RegierD, eds. Arlington, VA: American Psychiatric Association; 2002:1–29.
29.
RegierDA, NarrowWE, KuhlEA, eds. The conceptual evolution of DSM-5. Arlington, VA: American Psychiatric Publishing, Inc; 2011.
30.
HelzerJE.A proposal for incorporating clinically relevant dimensions into DSM-5. In: The conceptual evolution of DSM-5. RegierDA, NarrowWE, KuhlEA, eds. Arlington, VA: American Psychiatric Publishing, Inc; 2011:81–96.
31.
PosternakMA, ZimmermanM, SolomonDA.Integrating outcomes research into clinical practice. Psychiatr Serv. 2002;53:335–336.
32.
TrivediMH, RushAJ, WisniewskiSR, . Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40.
33.
ZimmermanM, McGlincheyJB, ChelminskiI.An inadequate community standard of care: lack of measurement of outcome when treating depression in clinical practice. Primary Psychiatry. 2008;15:67–75.
34.
ZimmermanM, PosternakMA, ChelminskiI.Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?J Nerv Ment Dis.2005;193:170–175.
35.
ZimmermanM, MartinezJ, AttiullahN, . Further evidence that the cutoff to define remission on the 17-item Hamilton Depression Rating Scale should be lowered. Depress Anxiety. 2012;29:159–165.
36.
ZimmermanM, ChelminskiI, YoungD, . Is dimensional scoring of borderline personality disorder only important for subthreshold levels of severity?J Pers Disord.2013;27:244–251.
37.
WittchenHU, HoflerM, GlosterAT, . Options and dilemmas of dimensional measures for DSM-5: Which types of measures fare best in predicting course and outcome?In: The conceptual evolution of DSM-5.RegierDA, NarrowWE, KuhlEA, eds. Arlington, VA: American Psychiatric Publishing, Inc; 2011:119–143.
38.
ZimmermanM, MattiaJI.A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001;58:787–794.
39.
UherR, PayneJL, PavlovaB, . Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV. Depress Anxiety. 2013;31:459–471.
40.
BögelsSM, AldenL, BeidelDC, . Social anxiety disorder: questions and answers for the DSM-V. Depress Anxiety. 2010;27:168–189.
41.
Le BeauRT, GlennD, LiaoB, . Specific phobia: a review of DSM-IV specific phobia and preliminary recommendations for DSM-V. Depress Anxiety. 2010;27:148–167.
